• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by ContextLogic Inc.

    4/15/25 8:03:03 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $LOGC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    ContextLogic Inc.

    (Name of Issuer)


    Class A Common Stock, Par Value $0.0001 Per Share

    (Title of Class of Securities)


    21077C107

    (CUSIP Number)


    03/28/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    21077C107


    1Names of Reporting Persons

    Islet Management, LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,612,900.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,612,900.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,612,900.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.83 %
    12Type of Reporting Person (See Instructions)

    IA

    Comment for Type of Reporting Person:  *Reflects beneficial ownership consisting of shares of Common Stock and shares of Common Stock issuable upon exercise of call options.


    SCHEDULE 13G

    CUSIP No.
    21077C107


    1Names of Reporting Persons

    Joseph Samuels
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,612,900.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,612,900.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,612,900.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.83 %
    12Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:  *Reflects beneficial ownership consisting of shares of Common Stock and shares of Common Stock issuable upon exercise of call options.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    ContextLogic Inc.
    (b)Address of issuer's principal executive offices:

    2648 International Blvd., Ste 115, Oakland, California, 94601
    Item 2. 
    (a)Name of person filing:

    This Schedule 13G filing relates to shares of Class A Common Stock, $0.0001 par value per share (the "Common Stock"), of the Issuer. This Schedule 13G is being filed on behalf of the following persons/entities (collectively, the "Reporting Persons"): Islet Management, LP ("Islet") Joseph Samuels
    (b)Address or principal business office or, if none, residence:

    590 Madison Avenue, 27th Floor New York, NY 10022
    (c)Citizenship:

    Islet is organized under the laws of the State of Delaware. Joseph Samuels is a United States citizen.
    (d)Title of class of securities:

    Class A Common Stock, Par Value $0.0001 Per Share
    (e)CUSIP No.:

    21077C107
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    The responses to Items 5-11 of the cover pages of this Schedule 13G are incorporated herein by reference. Islet acts as investment manager to, and exercises investment discretion with respect to an account that holds the securities of the Issuer described herein (the "Account"). Mr. Samuels is the Chief Executive Officer and Chief Investment Officer of Islet. As investment manager to the Account, Islet, pursuant to an Account Investment Advisory Agreement, has discretionary investment authority and voting power with respect to the Common Stock beneficially owned by the Account. Thus, it could be deemed to have the power to vote and dispose or direct the disposition of such Common Stock held by the Account. As the Chief Executive Officer and Chief Investment Officer of Islet, Mr. Samuels has the ability to exercise investment discretion over the Account. Thus, he could be deemed to share the power to vote and dispose or direct the disposition of the Common Stock beneficially owned by the Account. As of April 10, 2025, the Account directly beneficially owned 1,612,900 shares of Common Stock representing 5.83% of the shares of Class A Common Stock outstanding, including 1,375,400 shares of Common Stock issuable upon exercise of call options. Calculations of the percentage of shares of Common Stock beneficially owned are based on 26,313,619 shares of Common Stock outstanding as of February 28, 2025, as reported in the Quarterly Report on Form 10-K filed by the Issuer with the Securities and Exchange Commission on March 12, 2025. The Reporting Persons note that the calculation of beneficial ownership for purposes of this Schedule 13G is different than the calculation of ownership under the terms of the Issuer's Tax Benefits Preservation Plan, dated as of February 10, 2024 (the "382 Plan"). For purposes of the 382 Plan, the Reporting Persons collectively own less than 4.9% as a result of the exclusion of shares owned by the Account issuable upon exercise of call options.
    (b)Percent of class:

    See Item 4(a) above
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See Item 5 of each cover page hereof.

     (ii) Shared power to vote or to direct the vote:

    See Item 6 of each cover page hereof.

     (iii) Sole power to dispose or to direct the disposition of:

    See Item 7 of each cover page hereof.

     (iv) Shared power to dispose or to direct the disposition of:

    See Item 8 of each cover page hereof.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Islet Management, LP
     
    Signature:/s/ Rebecca Waldman
    Name/Title:General Counsel
    Date:04/15/2025
     
    Joseph Samuels
     
    Signature:/s/ Joseph Samuels
    Name/Title:Joseph Samuels
    Date:04/15/2025
    Get the next $LOGC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LOGC

    DatePrice TargetRatingAnalyst
    2/3/2022Outperform → Market Perform
    William Blair
    2/2/2022$16.00 → $6.00Hold
    Chardan Capital
    12/23/2021$20.00 → $16.00Buy
    Chardan Capital
    11/17/2021$24.00 → $8.00Overweight
    Barclays
    11/16/2021$17.00 → $16.00Market Outperform
    JMP Securities
    More analyst ratings

    $LOGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • LogicBio Therapeutics downgraded by William Blair

      William Blair downgraded LogicBio Therapeutics from Outperform to Market Perform

      2/3/22 4:38:49 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chardan Capital reiterated coverage on LogicBio Therapeutics with a new price target

      Chardan Capital reiterated coverage of LogicBio Therapeutics with a rating of Hold and set a new price target of $6.00 from $16.00 previously

      2/2/22 2:52:41 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chardan Capital reiterated coverage on LogicBio Therapeutics with a new price target

      Chardan Capital reiterated coverage of LogicBio Therapeutics with a rating of Buy and set a new price target of $16.00 from $20.00 previously

      12/23/21 8:24:38 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    SEC Filings

    See more
    • SEC Form 10-Q filed by ContextLogic Inc.

      10-Q - ContextLogic Inc. (0001822250) (Filer)

      5/9/25 4:30:19 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ContextLogic Inc. (0001822250) (Filer)

      5/9/25 4:05:15 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SCHEDULE 13G/A filed by ContextLogic Inc.

      SCHEDULE 13G/A - ContextLogic Inc. (0001822250) (Subject)

      4/18/25 3:58:12 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Bajaj Rishi converted options into 55,856 shares and covered exercise/tax liability with 24,722 shares, increasing direct ownership by 156% to 51,134 units (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      5/8/25 4:10:12 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Director Heinberg Marshall converted options into 25,684 shares (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      4/21/25 8:44:49 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Director Farlekas Michael converted options into 25,684 shares (SEC Form 4)

      4 - ContextLogic Inc. (0001822250) (Issuer)

      4/21/25 8:44:13 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ContextLogic Inc. Reports First-Quarter 2025 Financial Results

      OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, 2025. First-Quarter 2025 Financial Highlights Net Loss: Net loss was $4 million, compared to a net loss of $59 million in the first quarter of fiscal year 2024.As of March 31, 2025, the Company had $64 million in cash and cash equivalents, $158 million in marketable securities and $1 million in prepaid expenses and other current assets primarily made up of restricted cash. The Company had total liabilities of $3 million. ContextLogic will host a financial results conference call a

      5/9/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic to Announce First Quarter 2025 Results on May 9, 2025

      OAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") today announced it will report its first quarter 2025 financial results after the close of market on Friday, May 9, 2025. ContextLogic's CEO Rishi Bajaj and its Chairman Ted Goldthorpe will host a live conference call and webcast for shareholders, analysts and portfolio managers that afternoon at 5:00 PM ET / 2:00 PM PT. Information about the Company's financial results, including a link to the live webcast and replay will be made available on the Company's investor relations website at https://ir.contextlogicinc.com. The live conference call may be accessed by registering

      5/6/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

      OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and fiscal year ended December 31, 2024. Company Update During 2024, management took several significant steps in the evolution of the Company's business. These included, first, the sale of the Wish platform and its associated operations; second, streamlining the Company's operations; and most recently, on March 11, 2025, the Company announced the initial closing of the investment by BC Partners of $75 million in convertible preferred units in a subsidiary of ContextLogic. This investment, along

      3/12/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Financials

    Live finance-specific insights

    See more
    • ContextLogic Inc. Reports First-Quarter 2025 Financial Results

      OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, 2025. First-Quarter 2025 Financial Highlights Net Loss: Net loss was $4 million, compared to a net loss of $59 million in the first quarter of fiscal year 2024.As of March 31, 2025, the Company had $64 million in cash and cash equivalents, $158 million in marketable securities and $1 million in prepaid expenses and other current assets primarily made up of restricted cash. The Company had total liabilities of $3 million. ContextLogic will host a financial results conference call a

      5/9/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic to Announce First Quarter 2025 Results on May 9, 2025

      OAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") today announced it will report its first quarter 2025 financial results after the close of market on Friday, May 9, 2025. ContextLogic's CEO Rishi Bajaj and its Chairman Ted Goldthorpe will host a live conference call and webcast for shareholders, analysts and portfolio managers that afternoon at 5:00 PM ET / 2:00 PM PT. Information about the Company's financial results, including a link to the live webcast and replay will be made available on the Company's investor relations website at https://ir.contextlogicinc.com. The live conference call may be accessed by registering

      5/6/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

      OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and fiscal year ended December 31, 2024. Company Update During 2024, management took several significant steps in the evolution of the Company's business. These included, first, the sale of the Wish platform and its associated operations; second, streamlining the Company's operations; and most recently, on March 11, 2025, the Company announced the initial closing of the investment by BC Partners of $75 million in convertible preferred units in a subsidiary of ContextLogic. This investment, along

      3/12/25 4:00:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ContextLogic Inc.

      SC 13G/A - ContextLogic Inc. (0001822250) (Subject)

      7/8/24 4:32:41 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13G/A filed by LogicBio Therapeutics Inc. (Amendment)

      SC 13G/A - LogicBio Therapeutics, Inc. (0001664106) (Subject)

      2/14/23 1:47:10 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SC 13D/A filed by LogicBio Therapeutics Inc. (Amendment)

      SC 13D/A - LogicBio Therapeutics, Inc. (0001664106) (Subject)

      2/10/23 4:40:05 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary

    $LOGC
    Leadership Updates

    Live Leadership Updates

    See more
    • ContextLogic Announces Up to $150 Million Strategic Investment by BC Partners

      Strategic investment and capital commitment positions the Company to execute on its stated acquisition-led value maximization strategy; ContextLogic to have up to $300 million of investible cash Ted Goldthorpe, Head of BC Partners Credit, expected to be named Chairman of the Board OAKLAND, Calif. and NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") and BC Partners, an alternative investment manager with c.€40 billion in assets under management, today announced that a fund advised by BC Partners Advisors L.P. will purchase up to $150 million of convertible preferred units (the "Preferred Units") of ContextLogic Holdings, L

      2/25/25 8:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • LogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business Updates

      LEXINGTON, Mass., March 4, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today reported financial results for the year ended December 31, 2021, and provided business updates. "At LogicBio, we are continuing to advance our mission to safely deliver novel genetic medicines to people impacted by devastating, early onset diseases," said Frederic Chereau, president and chief executive officer of LogicBio. "We are pleased to report that the serious adverse event experienced by the fourth patient enrolled in our Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with methylmalonic acidemia has resolved." Recent Business Update

      3/4/22 4:05:00 PM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary
    • LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments

      LEXINGTON, Mass., May 19, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced the promotion of Daniel Gruskin, MD, as chief medical officer. Dr. Gruskin most recently served as senior vice president and head of clinical development. The Company also announced the appointment of Stephen Boyer, PhD, as vice president of regulatory and quality affairs, and Peter Pechan, PhD, as vice president of gene therapy, who will support progress in the Phase I/II SUNRISE clinical trial of LB-001, the Company's investi

      5/19/21 7:00:00 AM ET
      $LOGC
      Catalog/Specialty Distribution
      Consumer Discretionary